All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The Lupus Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Improving outcomes for people of color with chronic plaque psoriasis including scalp involvement
with Paolo Gisondi, Andrew Alexis, and Mona Shahriari
Thursday, February 6, 2025
16:00-17:00 GMT
This independent educational activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. All content is developed independently by the faculty. The funder is allowed no influence on the content.
The Lupus Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lupus Hub cannot guarantee the accuracy of translated content. The Lupus Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lupus Hub is an independent medical education platform, supported through a grant from AstraZeneca. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Laurent ArnaudSteering Committee Member
Laurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University & Academic Hospitals, France. His main clinical interests focus on the care of patients with Systemic Lupus Erythematosus (SLE). He is leading a research group focusing on innovative strategies for holistic SLE care using novel diagnostic and therapeutic digital strategies. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has published more than 300 articles in the field of rare diseases and is currently leading several international taskforces such as the Treat-to-target (T2T) taskforce and the SLICC/ReCONNET/SLEuro recommendations for rare manifestations in SLE. Professor Arnaud is currently the President of the European Lupus Society (SLEuro) and Disease Coordinator for Lupus of the European Reference Network for rare diseases ReCONNET. He is the curator of a twitter account (@lupusreference) about lupus education, followed by >16.5k people.